ORBIMED ADVISORS LLC Insider Trading $ARYX ARYx Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ORBIMED ADVISORS LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ORBIMED ADVISORS LLC. ORBIMED ADVISORS LLC is Director in INSULET CORP ($PODD) and 10% Owner in CRYOCOR INC ($CRYO) and Director in CRYOCOR INC ($CRYO) and 10% Owner in Anthera Pharmaceuticals Inc ($ANTH) and Director in Biodel Inc ($BIOD) and Director in NxStage Medical, Inc. ($NXTM) and Director in ATHERSYS, INC / NEW ($ATHX) and 10% Owner in ARYx Therapeutics, Inc. ($ARYX) and Director in ARYx Therapeutics, Inc. ($ARYX).
ORBIMED ADVISORS LLC in ARYx Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: 10% Owner, Director
Holdings: 1,340,139 shares
Current Value: $0
Latest Transaction: May 26 2009
$ARYX Market Capitalization: $117113.50
$ARYX Previous Close: $0.00
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of ORBIMED ADVISORS LLC in ARYx Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALBO, ANTH, ARYX, ATHX, CRYO, PODD, NXTM
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 26 2009 | ARYX | ARYx Therapeutics, ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | P | 2.64 | 364,395 | 962,003 | 364,395 | |
| May 26 2009 | ARYX | ARYx Therapeutics, ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 4.00 | 2,000,000 | 8,000,000 | 1,340,139 | 3.3 M to 1.3 M (-59.88 %) |
| Nov 18 2008 | ARYX | ARYx Therapeutics, ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | P | 2.64 | 364,395 | 962,003 | 364,395 | |
| Nov 18 2008 | ARYX | ARYx Therapeutics, ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 0.00 | 1,214,646 | 0 | 3,340,139 | 2.1 M to 3.3 M (+57.15 %) |
| Nov 15 2007 | ARYX | ARYx Therapeutics, ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 323,399 | 0 | 0 | |
| Nov 15 2007 | ARYX | ARYx Therapeutics, ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 604,228 | 0 | 0 | |
| Nov 15 2007 | ARYX | ARYx Therapeutics, ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 897,866 | 0 | 0 | |
| Nov 15 2007 | ARYX | ARYx Therapeutics, ... | ORBIMED ADVISORS LLC | Director | Buy | P | 10.00 | 300,000 | 3,000,000 | 2,125,493 | 1.8 M to 2.1 M (+16.43 %) |
| Nov 15 2007 | ARYX | ARYx Therapeutics, ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 1,825,493 | 0 | 1,825,493 | 0 to 1.8 M |
Page: 1